Scinovex
reviewTop 1% cited

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

Schizophrenia Research · 1999 · Vol. 35(1) · pp. 51–68
Stefan LeuchtGabriele Pitschel‐WalzDanielle S. AbrahamWerner Kissling
Schizophrenia research and treatmentBipolar Disorder and TreatmentEpilepsy research and treatmentSertindoleQuetiapineOlanzapineRisperidoneHaloperidolAntipsychoticExtrapyramidal symptomsPlaceboPsychologyTolerability

MeSH terms

Quetiapine FumarateOlanzapineBasal Ganglia DiseasesBenzodiazepinesDibenzothiazepinesDouble-Blind MethodHaloperidolHumansImidazolesIndolesPirenzepineSchizophreniaAntipsychotic AgentsRandomized Controlled Trials as TopicRisperidone
Citations
802
FWCI
25.18
field-weighted impact
References
99
Percentile
100%
vs. same field & year
Citations per year
References
Olanzapine versus Placebo and Haloperidol
Neuropsychopharmacology · 1996 · 785 citations
Clozapine for the Treatment-Resistant Schizophrenic
Archives of General Psychiatry · 1988 · 4,110 citations
Negative Symptoms in Schizophrenia
Archives of General Psychiatry · 1982 · 2,238 citations
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
Schizophrenia Bulletin · 1987 · 21,169 citations
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
Acta Psychiatrica Scandinavica · 1970 · 3,256 citations
Comprehensive Textbook of Psychiatry
The American Journal of the Medical Sciences · 1967 · 3,829 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials · Scinovex